您要查找的是不是：
- total vascular resistance 總血管阻力
- However,Bromocriptine did not alter systemic vascular resistance. 氟呱啶醇能阻斷溴隱亭這一作用；
- AIM: To monitor the changes of total systemic vascular resistance (TSVR) and stroke volume (SV) during fluid therapy by transesophageal echo Doppler and to explore the correlation between TSVR and SV. 目的:應用經(jīng)食管超聲多普勒血液動(dòng)力學(xué)監測儀,觀(guān)察液體治療時(shí)每搏量(SV)與全身血管阻力(TSVR)的變化,并分析兩者的相關(guān)性。
- There was a tendency for the pulmonary vascular resistance to decrease in HS and HSD groups as compared with NS group. 與NS組比較,HS組和HSD治療后肺血管阻力呈下降趨勢。
- The HPHR has more vascular bundles and a much bigger area of single vascular bundle, total vascular bundle, total phloem and total xylem in the first internode than Shanyou 63. 結果表明，重穗型組合的大維管束數目、單個(gè)維管束面積及維管束總面積、韌皮部總面積均明顯高于汕優(yōu)63。
- Arteriolar relaxation reduces systemic vascular resistance and arterial pressure(afterload). 心臟指數可增加、降低或不變。
- Significantly increase in coronary blood flow due to reduction of vascular resistance. 可增加冠狀動(dòng)脈流量，因為丹參能減低血管阻力。
- total peripheral vascular resistance 周?chē)茏枇偤? 末梢血管總阻力
- There was no difference of other parameters [cerebral vascular resistance (CVR), compliance, Co and CP] in every group (P>0.05). 其他各項參數(腦血管阻力、順應性、零壓順應性、臨界壓力)各組間無(wú)差異(P>0．05)。
- Results and Conclusion: Inhaled iloprost can reduce pulmonary vascular resistance and delay the development of primary pulmonary hypertension. 結果和結倫：吸入性伊洛前列素治療可以降低肺血管阻力和延緩原發(fā)性肺動(dòng)脈高壓的進(jìn)程。
- Diltiazem is a benzothiazepine derivative calcium antagonist，which produces antihypertensive effect primarily by relaxation of vascular resistance. 地爾硫卓是一種苯噻氮卓類(lèi)鈣拮抗劑，作用于血管平滑肌使外周血管擴張，心臟后負荷降低，發(fā)揮降壓作用。
- With prazosin, the average cardiac index increased (by) 20 percent and systemic vascular resistance decreased (by) 20 percent. 使用哌唑嗪，平均心臟指數增加20%25，全身血管阻力下降20%25。
- Conclusion: Epidural anesthesia increase umbilical blood flow，but does not change the umbilical vascular resistance, which is benefical for foetus. 結論： 硬膜外阻滯后可增加臍血流而不增加臍血管阻力，對胎兒血供是有利的。
- Results and Conclusion:Inhaled iloprost can reduce pulmonary vascular resistance and delay the development of primary pulmonary hypertension. 結果和結論:吸入性伊洛前列素治療可以降低肺血管阻力和延緩原發(fā)性肺動(dòng)脈高壓的進(jìn)程。
- Introduction: Reperfusion syndrome in liver transplant patients is characterized by labile systemic vascular resistance (SVR) and cardiac output (CO). 簡(jiǎn)介： 肝移植患者發(fā)生再灌注綜合征的特征是體循環(huán)阻力（SVR）不穩定和心輸出量（CO）不穩定。
- total pulmonary vascular resistance 肺血管總阻力
- total systemic vascular resistance 全身血管總阻力, 體循環(huán)血管總阻力
- total systemic vascular resistance index 全身血管總阻力指數
- Endothelin-1 contributes to increased systemic vascular resistance,vascular remoulding,left ventricular dysfunction and renal impairment in essential hypertension. 原發(fā)性高血壓時(shí)血漿內皮素-1水平升高,可導致外周阻力增加,并且通過(guò)激活ETA和ETB受體可加重高血壓病心、腎、動(dòng)脈系統的損害,形成惡性循環(huán)。
- RESULTS &CONCLUSION: The feature of PAH is that pulmonary vascular resistance progressively increases,and finally leads to right heart failure and death. 結果與結論:肺動(dòng)脈高壓的特點(diǎn)是肺血管阻力進(jìn)行性增加,最終導致右心衰竭和死亡。
